These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35326734)

  • 1. Immunophenotypic Analysis of Acute Megakaryoblastic Leukemia: A EuroFlow Study.
    Brouwer N; Matarraz S; Nierkens S; Hofmans M; Nováková M; da Costa ES; Fernandez P; Bras AE; de Mello FV; Mejstrikova E; Philippé J; Grigore GE; Pedreira CE; van Dongen JJM; Orfao A; van der Velden VHJ; On Behalf Of The EuroFlow Consortium
    Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunophenotype of Down syndrome acute myeloid leukemia and transient myeloproliferative disease differs significantly from other diseases with morphologically identical or similar blasts.
    Langebrake C; Creutzig U; Reinhardt D
    Klin Padiatr; 2005; 217(3):126-34. PubMed ID: 15858703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixed phenotype of blasts in acute megakaryocytic leukaemia and transient abnormal myelopoiesis in Down's syndrome.
    Yumura-Yagi K; Hara J; Kurahashi H; Nishiura T; Kaneyama Y; Osugi Y; Sakata N; Inoue M; Tawa A; Okada S
    Br J Haematol; 1992 Aug; 81(4):520-5. PubMed ID: 1390239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute megakaryoblastic leukemia associated with trisomy 21 demonstrates a distinct immunophenotype.
    Wang L; Peters JM; Fuda F; Li L; Karandikar NJ; Koduru P; Wang HY; Chen W
    Cytometry B Clin Cytom; 2015; 88(4):244-52. PubMed ID: 25361478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute Megakaryoblastic Leukemia Associated with Trisomy 21 Demonstrates a Distinct Immunophenotype.
    Wang L; Peters JM; Fuda F; Li L; Karandikar NJ; Koduru P; Wang H; Chen W
    Cytometry B Clin Cytom; 2014 Oct; ():. PubMed ID: 25302938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of CD36 as a novel addition to the immunophenotypic signature of RAM-phenotype acute myeloid leukemia and study of its clinicopathological characteristics.
    Panda D; Chatterjee G; Sardana R; Khanka T; Ghogale S; Deshpande N; Badrinath Y; Shetty D; Narula G; Banavali S; Patkar NV; Gujral S; Subramanian PG; Tembhare PR
    Cytometry B Clin Cytom; 2021 Mar; 100(2):206-217. PubMed ID: 32865882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric Non-Down Syndrome Acute Megakaryoblastic Leukemia With Unusual Immunophenotype.
    Koulmane Laxminarayana SL; Kohli S; Agrohi J; Belurkar S
    Cureus; 2023 Mar; 15(3):e35965. PubMed ID: 36911590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunophenotypic markers for the evaluation of minimal/measurable residual disease in acute megakaryoblastic leukemia.
    Pinto CM; Bertolucci CM; Severino AR; Dos Santos Tosi JF; Ikoma-Colturato MRV
    Hematol Transfus Cell Ther; 2024; 46(4):542-548. PubMed ID: 38008596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunologic characteristics and prognosis of acute myeloid leukemia M1].
    Zhao F; Chen Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):687-91. PubMed ID: 17708783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal Myeloproliferative Disorders in Patients with Down Syndrome-Treatment and Outcome Results from an Institution in Argentina.
    Pennella CL; Cassina TM; Rossi JG; Baialardo EM; Rubio P; Deu MA; Peruzzo L; Guitter MR; Sanchez de La Rosa CG; Alfaro EM; Felice MS
    Cancers (Basel); 2022 Jul; 14(13):. PubMed ID: 35805057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in molecular characterization of pediatric acute megakaryoblastic leukemia not associated with Down syndrome; impact on therapy development.
    Li J; Kalev-Zylinska ML
    Front Cell Dev Biol; 2023; 11():1170622. PubMed ID: 37325571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical impact of genomic characterization of 15 patients with acute megakaryoblastic leukemia-related malignancies.
    Lalonde E; Rentas S; Wertheim G; Cao K; Surrey LF; Lin F; Zhao X; Obstfeld A; Aplenc R; Luo M; Li MM
    Cold Spring Harb Mol Case Stud; 2021 Apr; 7(2):. PubMed ID: 33832921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of immunophenotype and leukemia associated immunophenotype in 610 patients with acute myeloid leukemia].
    Liu YR; Wang YZ; Chen SS; Chang Y; Fu JY; Li LD; Wang H; Yu H; Jiang B; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):731-6. PubMed ID: 18457262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The immunophenotypic and clinical characteristics of NPM1 mutated acute myeloid leukemia patients].
    Liu YR; Chang Y; Ruan GR; Qin YZ; Lai YY; Shi HX; Wang YZ; Li LD; Jiang B; Li JL
    Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):98-103. PubMed ID: 23611213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down syndrome and malignancies: a unique clinical relationship: a paper from the 2008 william beaumont hospital symposium on molecular pathology.
    Xavier AC; Ge Y; Taub JW
    J Mol Diagn; 2009 Sep; 11(5):371-80. PubMed ID: 19710397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient myeloproliferative disorder and acute myeloid leukemia in Down syndrome. An immunophenotypic analysis.
    Karandikar NJ; Aquino DB; McKenna RW; Kroft SH
    Am J Clin Pathol; 2001 Aug; 116(2):204-10. PubMed ID: 11488066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revealing the intratumoral heterogeneity of non-DS acute megakaryoblastic leukemia in single-cell resolution.
    Su N; Li Z; Yang J; Fu Y; Zhu X; Miao H; Yu Y; Jiang W; Le J; Qian X; Wang H; Qian M; Zhai X
    Front Oncol; 2022; 12():915833. PubMed ID: 36003795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD36 (thrombospondin receptor) expression in childhood acute megakaryoblastic leukemia: in vitro drug sensitivity and outcome.
    Savaşan S; Buck S; Raimondi SC; Becton DL; Weinstein H; Chang M; Ravindranath Y
    Leuk Lymphoma; 2006 Oct; 47(10):2076-83. PubMed ID: 17071479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated differential transcriptome maps of Acute Megakaryoblastic Leukemia (AMKL) in children with or without Down Syndrome (DS).
    Pelleri MC; Piovesan A; Caracausi M; Berardi AC; Vitale L; Strippoli P
    BMC Med Genomics; 2014 Dec; 7():63. PubMed ID: 25476127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric non-Down's syndrome acute megakaryoblastic leukemia patients in China: A single center's real-world analysis.
    Zhang A; Liu L; Zong S; Chen X; Liu C; Chang L; Chen X; Yang W; Guo Y; Zhang L; Zou Y; Chen Y; Zhang Y; Ruan M; Zhu X
    Front Oncol; 2022; 12():940725. PubMed ID: 36267971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.